Drugs / glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine
glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00612001 | May 2006 → Jan 2011 | central nervous system neoplasm | Jonsson Comprehensive Cancer Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00612001 ↗ |
| Modality | Vaccine | “GAA peptide-pulsed autologous dendritic cell vaccine” NCT00612001 ↗ |